Interpace Diagnostics Corp. (NASDAQ: IDXG), a company that provides specialized molecular diagnostic tests and pathology services, announced today that the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE